Stocks and Investing
Stocks and Investing
Tue, March 30, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 29, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (BLUE) at Buy with Increased Target to $72 on, Mar 29th, 2021
Mani Foroohar of SVB Leerink, Maintained "bluebird bio, Inc." (BLUE) at Buy with Increased Target from $69 to $72 on, Mar 29th, 2021.
Mani has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $45 on, Tuesday, March 2nd, 2021
- Cory Kasimov of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $39 on, Wednesday, February 17th, 2021
This is the rating of the analyst that currently disagrees with Mani
- Difei Yang of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $69 on, Wednesday, March 10th, 2021
Contributing Sources